Summary
- Current Price
- As of today, TGTX price is $29.46, up +0.79% on
- Current Price All-Time High
- TGTX price is currently -87.38% below its historical high of $233.44 set on
- Market Cap
- TGTX current market cap is $5B, down -3.22% year-over-year
- PE Ratio
- TGTX current PE ratio is 10.60
- Revenue
- TGTX current annual revenue is $329.00M, up +40.80% year-over-year
- Next Earnings
- The next earnings release for TGTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | TG Therapeutics, Inc. |
| Ticker | NASDAQ: TGTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tgtherapeutics.com |
| Employees | 352 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $29.46 | |
| Price, 1D Change | +0.79% | |
| $5B | ||
| - | ||
| 10.60 | ||
| 0.49 | ||
| $329M | ||
| Revenue, 1Y Change | +40.80% | |
| $0.15 | ||
| EPS, 1Y Change | +70.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 4:225 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MHAN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.15 | ||
| EPS Estimate | $2.97 | |
| EPS Est. Change | +1,936.28% | |
| $329.00M | ||
| Revenue Estimate | $617.13M | |
| Revenue Est. Change | +87.58% | |
| Current Price | $29.46 | |
| Price Target | - | $46.00 |
| Price Tgt. Change | - | +56.14% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.09 | $0.09 | -5.22% | |
| $0.16 | $0.15 | -9.72% | |
| $2.97 | N/A | +1,936.28% | |
| $1.62 | N/A | +1,011.59% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $231.11M | $233.66M | +1.10% | |
| $321.55M | $329.00M | +2.32% | |
| $617.13M | N/A | +87.58% | |
| $897.64M | N/A | +172.83% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $29.46 | |
| $32.89 | ||
| SMA 200 vs Price | +11.65% | |
| $30.02 | ||
| SMA 50 vs Price | +1.90% | |
| 0.49 | ||
| $1.12 | ||
| 49.48 | ||
| 38.79% | ||
| 49.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $329.00M | ||
| $0.15 | ||
| $290.24M | ||
| 88.22% | ||
| $41.93M | ||
| 12.74% | ||
| $23.38M | ||
| 7.11% | ||
| $49.90M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.10 | ||
| 6.25 | ||
| 5.03 | ||
| - | ||
| 4 | ||
| 6.03 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 10.60 | ||
| 8.79 | ||
| 7.70 | ||
| 46.59 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $222.36M | ||
| $179.89M | ||
| $577.69M | ||
| $566.36M | ||
| $355.33M | ||
| $90.68M | ||
| $253.72M | ||
| $1.16M | ||
| $58.30M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $287.08M | ||
| $248.59M | ||
| $38.77M | ||
| $154.30M | ||
| $280.00K | ||
| $0.00 | ||
| $2.21M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$40.52M | ||
| -$1.04M | ||
| $128.53M | ||
| $45.00K | ||
| -$40.56M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Goldman Sachs | → | |
| JP Morgan | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| Goldman Sachs | → | |
| TD Cowen |
Analyst sentiment
Institutional ownership
Screeners with TGTX
FAQ
What is the ticker symbol for TG Therapeutics, Inc.?
The ticker symbol for TG Therapeutics, Inc. is NASDAQ:TGTX
Does TG Therapeutics, Inc. pay dividends?
No, TG Therapeutics, Inc. does not pay dividends
What sector is TG Therapeutics, Inc. in?
TG Therapeutics, Inc. is in the Healthcare sector
What industry is TG Therapeutics, Inc. in?
TG Therapeutics, Inc. is in the Biotechnology industry
What country is TG Therapeutics, Inc. based in?
TG Therapeutics, Inc. is headquartered in United States
When did TG Therapeutics, Inc. go public?
TG Therapeutics, Inc. initial public offering (IPO) was on May 3, 2010
Is TG Therapeutics, Inc. in the S&P 500?
No, TG Therapeutics, Inc. is not included in the S&P 500 index
Is TG Therapeutics, Inc. in the NASDAQ 100?
No, TG Therapeutics, Inc. is not included in the NASDAQ 100 index
Is TG Therapeutics, Inc. in the Dow Jones?
No, TG Therapeutics, Inc. is not included in the Dow Jones index
When was TG Therapeutics, Inc. last earnings report?
TG Therapeutics, Inc.'s most recent earnings report was on November 3, 2025
When does TG Therapeutics, Inc. report earnings?
The next expected earnings date for TG Therapeutics, Inc. is March 2, 2026
Data Sources & References
- TGTX Official Website www.tgtherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1001316/000143774925005908/0001437749-25-005908-index.htm
- TGTX Profile on Yahoo Finance finance.yahoo.com/quote/TGTX
- TGTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tgtx